Institution
The Pirbright Institute
- Biotech
- Founded:
- 1914
- Headquarters:
- Ash, United Kingdom
- Parent:
- Biotechnology and Biological Sciences Research Council
Description
The Pirbright Institute researches livestock and zoonotic viral diseases, offers diagnostic testing and specialist facilities, and develops projects on vaccines, diagnostics and infectious-disease response.
Related
John Innes CentreSame parentJohn Innes Centre builds and conducts plant and microbial science research, producing publications, strategic programmes and translational…
GenDxGenDx develops and markets molecular diagnostic tests, software, services and educational products for high-resolution HLA typing and…
Institut PasteurInstitut Pasteur conducts basic and translational life‑science research and develops vaccines, diagnostics and training programs for public…
Fraunhofer Institute for Cell Therapy and ImmunologyFraunhofer IZI develops biomedical methods, materials, and products for therapies, vaccines, diagnostics, and extracorporeal treatments.
CytuvaxCytuvax develops therapeutic cancer vaccines and prophylactic vaccines against viral and bacterial pathogens using a depot-attached…
Cell and Gene Therapy CatapultCell and Gene Therapy Catapult builds collaborations, facilities and specialist services to help companies develop, manufacture and…
MultiplexDXMultiplexDX develops multiplexed molecular diagnostic tests and related sequencing, RNA FISH and bioinformatics services for cancer and…
HALIXHALIX is a biologics CDMO offering process development and manufacturing for viral vectors, vaccines, recombinant proteins, and aseptic…
Meridian BioscienceMeridian Bioscience provides life science products, molecular reagents, antibodies, antigens, blockers, services, and diagnostics platforms…
Ångström AIÅngström AI develops diagnostics using amplicon sequencing and machine learning, aiming to broaden access to sequencing-based diagnostic…
CeraVxCeraVx develops ceramic microneedle array patches (CeraMaps) for intradermal delivery of vaccines, therapeutics, diagnostics and…
OsivaxOsivax develops vaccines using its oligoDOM platform to elicit T-cell and B-cell immunity, producing clinical-stage vaccine candidates…